These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 2788188)

  • 1. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
    Mongini PK; Blessinger C; Posnett DN; Rudich SM
    J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
    Cambier JC; Monroe JG
    J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The riddle of the dual expression of IgM and IgD.
    Geisberger R; Lamers M; Achatz G
    Immunology; 2006 Aug; 118(4):429-37. PubMed ID: 16895553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1.
    Geisberger R; Königsberger S; Achatz G
    Immunol Lett; 2006 Feb; 102(2):169-76. PubMed ID: 16219364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and stimulatory signaling via immunoglobulin receptors: dichotomous responses elicited in clonal B cell populations.
    Van Endert PM; Moldenhauer G
    Eur J Immunol; 1992 May; 22(5):1229-35. PubMed ID: 1577065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
    Gaur A; Yao XR; Scott DW
    J Immunol; 1993 Mar; 150(5):1663-9. PubMed ID: 8436810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mIgM:mIgD ratios on B cells: mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells.
    Havran WL; DiGiusto DL; Cambier JC
    J Immunol; 1984 Apr; 132(4):1712-6. PubMed ID: 6421926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane IgM and IgD molecules fail to transduce Ca2+ mobilizing signals when expressed on differentiated B lineage cells.
    Justement LB; Wienands J; Hombach J; Reth M; Cambier JC
    J Immunol; 1990 May; 144(9):3272-80. PubMed ID: 2109774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen receptor-triggered apoptosis in immature B cell lines is associated with the binding of a 44-kDa phosphoprotein to the PTP1C tyrosine phosphatase.
    Wu Y; Pani G; Siminovitch K; Hozumi N
    Eur J Immunol; 1995 Aug; 25(8):2279-84. PubMed ID: 7664792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Ig-cytoskeletal interactions. I. Flow cytofluorometric and biochemical analysis of membrane IgM-cytoskeletal interactions.
    Albrecht DL; Noelle RJ
    J Immunol; 1988 Dec; 141(11):3915-22. PubMed ID: 3141508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking to the generation of an in vivo polyclonal antibody response.
    Goroff DK; Holmes JM; Bazin H; Nisol F; Finkelman FD
    J Immunol; 1991 Jan; 146(1):18-25. PubMed ID: 1984444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
    Mongini PK; Blessinger CA; Highet PF; Inman JK
    J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimer.
    Hartwig JH; Jugloff LS; De Groot NJ; Grupp SA; Jongstra-Bilen J
    J Immunol; 1995 Oct; 155(8):3769-79. PubMed ID: 7561081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between lymphocyte membrane molecules. II. Characterization of an interaction between B lymphocyte surface IgD and Fc IgG receptors that differs from the surface IgM-Fc IgG receptor interaction.
    Dickler HB; Kubicek MT; Finkelman FD
    J Immunol; 1982 Mar; 128(3):1271-7. PubMed ID: 6799572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pre-B and B cell membrane mu-chains are noncovalently associated with a disulfide-linked complex containing a product of the B29 gene.
    Clark MR; Friedrich RJ; Campbell KS; Cambier JC
    J Immunol; 1992 Nov; 149(9):2857-63. PubMed ID: 1401917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating mIgD-expressing B cells with anti-migis-δ monoclonal antibodies.
    Chen NY; Hung AF; Lin CJ; Chen JB; Chu HM; Yu HM; Chang HY; Chang TW
    Mol Immunol; 2013 Mar; 53(3):187-97. PubMed ID: 22944457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.